Wilson Sonsini Goodrich & Rosati represented Lyft in the offering, and Goodwin Procter represented the initial purchasers. Lyft, Inc. (“Lyft”) (NASDAQ: LYFT) closed its offering of 0.625%...
Lyft’s $460 Million Convertible Senior Notes Offering
ARTBIO’s Exclusive Strategic Collaboration with AlphaGen Therapeutics
Goodwin is representing ARTBIO on the matter. AlphaGen Therapeutics (“AlphaGen”), a biopharmaceutical company, and ARTBIO, Inc., a clinical-stage radiopharmaceutical company developing a new class of targeted...
AVROBIO’s Merger with Tectonic Therapeutic
Leerink Partners is serving as exclusive financial advisor to Tectonic and Cooley LLP is serving as legal counsel to Tectonic. Leerink Partners and TD Cowen are...
Renesas’ $339 Million Acquisition of Transphorm
Goodwin advised Renesas Electronics Corporation on the acquisition of Transphorm, assisted by Wilson Sonsini Goodrich & Rosati. On January 11, 2024, Renesas Electronics Corporation (Renesas, TSE:...
LENZ Therapeutics’ Merger with Graphite Bio
Wilson Sonsini Goodrich & Rosati is representing LENZ Therapeutics in the transaction, Goodwin Procter is representing Graphite Bio and Latham & Watkins is representing the placements...
IBM’s Acquisition of Manta Software
Goodwin Procter advised Manta Software in its acquisition by IBM. IBM acquired Manta Software Inc – a world-class data lineage platform — to complement its capabilities within...
Renesas Electronics Corporation’s $249 Million Acquisition of Sequans Communications
Goodwin advised Renesas Electronics Corporation, and Orrick advised Sequans. Renesas Electronics Corporation (TSE: 6723) and Sequans Communications S.A. (NYSE: SQNS) announced that the two companies have entered...
iRobot’s $200 Million Senior Secured Term Loan Financing
Goodwin advised iRobot on the financing, and Latham & Watkins advised Carlyle. iRobot Corporation (NASDAQ:IRBT) announced a $200 million senior secured term loan financing provided by...
Coherus’ Acquisition of Surface Oncology
Arnold & Porter advised Coherus Biosciences Inc. on the deal, and Goodwin advised Surface Oncology. Coherus Biosciences Inc. (Coherus) announced its acquisition of Surface Oncology Inc. (Surface),...
C4 Therapeutics’ Exclusive Licensing Agreement with Betta Pharmaceuticals
Goodwin Procter served as legal counsel to C4T, and Han Kun Law Offices served as legal counsel to Betta. C4 Therapeutics, Inc. announced its exclusive licensing agreement...
ElevateBio’s $401 Million Series D Financing Round
Goodwin advised ElevateBio on the financing. ElevateBio, LLC announced the closing of its $401 million Series D financing led by the AyurMaya Capital Management Fund, managed by...
Mercy BioAnalytics’ $41 Million Series A Financing
Goodwin advised Mercy BioAnalytics, Inc. on the deal. Mercy BioAnalytics, Inc. announced its $41 million Series A financing round. The financing was led by Novalis LifeSciences, with...